Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

Missing data in clinical trials remains an ongoing concern. With the expansion of data privacy efforts and the consequent inability to contact trial participants for follow-up, the magnitude and ...

Conducting studies in over 50 countries and regions, Caidya specializes in oncology and hematology, rare diseases, pediatrics, cell and gene therapy, cardiovascular, and dermatology. It has emerged as ...

Cutting Both Cost and TimeJoint Clinical Studies with CROs: SOMNUM™ AI Sleep Scoring Drives Higher EfficiencyFDA-cleared AI ...

A clinical oncology research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), in collaboration with ...

ANAHEIM, Calif.--(BUSINESS WIRE)--Truvian Health, a transformational and data-driven diagnostics company, today presented results from a recent multi-site clinical study at the 2023 American ...

The second Trump administration has been defined by widespread cuts to federal spending, including at the National Institutes ...

- Dr. Stanley Appel to present data from a proof-of-concept open-label clinical study in patients with ALS. - ALS patients were treated with Coya’s investigational biologic combination (COYA 302) ...

The NIH cuts affected over 115 clinical trials studying cancer and nearly 100 studying infectious disease, researchers found.

A single dose of a four-drug combination therapy for uncomplicated malaria was just as effective as the multi-day standard of ...